Repositioning Candidates
Repositioning candidates for CKD are derived from DrugBank which fall into three categories: therapeutic strategy-associated, target-associated, and indication-associated candidates. For each candidate, detailed properties are extracted from DrugBank, and related strategies, target and CKD-associated disease in CKDdb are presented with knowledge graphs.
stats1
stats2
stats3
Search for:
Angiotensin-converting enzyme16 records.
| Candidate ID | Source ID | Source Type | Compound Type | Candidate Name | Inclusion Criteria | |
|---|---|---|---|---|---|---|
| R0023 | DB00145 | approved; nutraceutical; vet_approved | small molecule | Glycine | Details | |
| R0024 | DB00146 | approved; nutraceutical | small molecule | Calcifediol | Details | |
| R0037 | DB00165 | approved; investigational; nutraceutical; vet_approved | small molecule | Pyridoxine | Details | |
| R0055 | DB00207 | approved | small molecule | Azithromycin | Details | |
| R0067 | DB00257 | approved; vet_approved | small molecule | Clotrimazole | Details | |
| R0076 | DB00291 | approved | small molecule | Chlorambucil | Details | |
| R0088 | DB00328 | approved; investigational | small molecule | Indomethacin | Details | |
| R0098 | DB00367 | approved; investigational | small molecule | Levonorgestrel | Details | |
| R0104 | DB00381 | approved | small molecule | Amlodipine | Details | |
| R0111 | DB00399 | approved | small molecule | Zoledronic acid | Details | |
| R0112 | DB00402 | approved; investigational | small molecule | Eszopiclone | Details | |
| R0123 | DB00438 | approved | small molecule | Ceftazidime | Details | |
| R0124 | DB00440 | approved; vet_approved | small molecule | Trimethoprim | Details | |
| R0135 | DB00480 | approved | small molecule | Lenalidomide | Details | |
| R0170 | DB00601 | approved; investigational | small molecule | Linezolid | Details | |
| R0183 | DB00640 | approved; investigational | small molecule | Adenosine | Details |